Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	144-149
Journal	Multiple Sclerosis and Related Disorders
Volume	25
DOIs	https://doi.org/10.1016/j.msard.2018.07.020
Publication status	Published - Oct 2018
Externally published	Yes

Access to Document

@article{5bcf8a84a4404a26b8327eac29e24923,

title = "Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia",

author = "Phan, \{Yen Hoang Le\} and Lourenco, \{Richard De Abreu\} and Marion Haas and Linden, \{Naomi van der\}",

year = "2018",

month = oct,

doi = "10.1016/j.msard.2018.07.020",

language = "English",

volume = "25",

pages = "144--149",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia

AU - Phan, Yen Hoang Le

AU - Lourenco, Richard De Abreu

AU - Haas, Marion

AU - Linden, Naomi van der

PY - 2018/10

Y1 - 2018/10

U2 - 10.1016/j.msard.2018.07.020

DO - 10.1016/j.msard.2018.07.020

M3 - Article

SN - 2211-0348

VL - 25

SP - 144

EP - 149

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

ER -